Mohammad Zamani Rarani

Mohammad Zamani Rarani

Auto-generated profile, based on publicly available information

Mohammad Zamani Rarani

Department of Anatomical Sciences, Medical School, Hormozgan University of Medical Sciences, Hormozgan, Iran

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Research in Pharmaceutical Sciences
Verified
Journal Article
Open access
MDMehdiNikbakht Dastjerdi
MehdiNikbakht Dastjerdi
MRMohammadZamani Rarani
MohammadZamani Rarani
AVAli Valiani
Ali Valiani
MMMohsen Mahmoudieh
Mohsen Mahmoudieh
Adenosine receptor family especially A1 type is expressed in breast cancer cells in which P53 and caspase genes are wild-type. The aim of this study was to investigate the correlation between A1 receptor and either cell apoptosis or proliferation and also to recognize the relationship between this receptor and P53 and the expression of caspases 3, 8 and 9 in MCF-7 cell line. MCF-7 cells were treated intermittently with A1 receptor agonist N6-Cyclopentyladenosine (CPA) and A1 receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) in different times to measure the expression of p53, caspase 3, 8 and 9 besides apoptosis and survival rate. Our findings indicated that DPCPX significantly induced apoptosis in MCF-7 cells while the cell viability was reduced specially 72 h after the treatment and the expression of p53 gene and caspase expressions was dramatically up-regulated. On the other hand, CPA increased the cell viability and reduced apoptosis in MCF-7 cells. Our results indicated a significant down-regulation in the MCF-7 mRNA expression of p53 and caspases 3, 8 and 9. Furthermore, DPCPX induced p53 and caspase 3, 8 and 9 expressions that consequently promotes the cell apoptosis in MCF-7 cells. Therefore, DPCPX can be considered as an anti-cancer drug.

15 December 2017 in Journal of Cardiovascular and Thoracic Research
Verified
Journal Article
Open access
MZMohammad Mahdi Zamani
Mohammad Mahdi Zamani
ANAtabak Najafi
Atabak Najafi
SSSaloomeh Sehat
Saloomeh Sehat
ZJZinat Janforooz
Zinat Janforooz
PDPooya Derakhshan
Pooya Derakhshan
MGMohammad Reza Ghodraty
Mohammad Reza Ghodraty
Introduction: This study aimed to evaluate the effects of high positive-end expiratory pressure (PEEP) and low tidal volume (TV) and recruitment maneuver, on postoperative pulmonary complications (PPCs) after coronary artery bypass grafting (CABG) surgery. Methods: This study is a randomized double blind clinical trial on 64 patients who were undergoing CABG surgery, and were randomly divided into two groups of conventional ventilation (C-Vent) with TV of 9 mL/kg and PEEP=0 cm H2O, and lung protective ventilation (P-Vent), with 6 mL/kg TV and PEEP=10 cm H2O with recruitment maneuver every 30 minutes. Measures of PPCs and modified clinical pulmonary infection score (mCPIS), were assessed for the first 24 hours of postoperative time in order to evaluate the pulmonary complications. Results: P-Vent with 31 patients and C-Vent with 30 patients, participated in the stage of data analysis. Demographic, and preoperative laboratory results showed no significant difference between two groups. During surgery, cardiovascular complications were higher in P-Vent group (P = 0.61) but pulmonary complications were higher in C-Vent group (P = 0.26). Extubation time was not significantly different between two groups, and also components of arterial blood gases (ABG) of 24 hours after surgery showed no significant difference between the two groups. Pathologic changes in the chest X-ray (CXR) of 24 hours after surgery, were lower in P-Vent group, but the difference was not significant (P = 0.22). The PPC criteria was less positive in P-Vent (2 patients) vs 9 patients in C-Vent group (P = 0.02) and mCPIS score was significantly lower in P-Vent group (1.2 ± 1.4) than C-Vent group (2 ± 1.6) (P = 0.048). Conclusion: Lung protective strategy during and after cardiac surgery, reduces the postoperative mCPIS in patients undergoing open heart surgery for CABG.

3 May 2013 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
MZM. Zamani
M. Zamani
MSMansooreh Soleimani
Mansooreh Soleimani
FGF. Golab
F. Golab
FMF. Mohamadzadeh
F. Mohamadzadeh
MMmehdi mehdizadeh
mehdi mehdizadeh
MKM. Katebi
M. Katebi

1 January 2016 in Bratislava Medical Journal
Verified
Journal Article
Closed access
MDM. Nikbakht Dastjerdi
M. Nikbakht Dastjerdi
AVAli Valiani
Ali Valiani
MMM. Mardani
M. Mardani
MRM. Zamani Ra
M. Zamani Ra
Adenosine A1 receptor modifies P53 expression and apoptosis in breast cancer cell line Mcf-7

1 January 2018 in Advanced Biomedical Research
Verified
Journal Article
Open access
MBMaryam Bahrami
Maryam Bahrami
AVAli Valiani
Ali Valiani
NANoushin Amirpour
Noushin Amirpour
MRMohammad Zamani Ra Rani
Mohammad Zamani Ra Rani
BHBatool Hashemibeni
Batool Hashemibeni
Background: Nowadays, cartilage tissue engineering is the best candidate for regeneration of cartilage defects. This study evaluates the function of herbal extracts icariin (ICA), the major pharmacological constituent of herba Epimedium, compared with transforming growth factor β3 (TGFβ3) to prove its potential effect for cartilage tissue engineering. Materials and Methods: ICA, TGFβ3, and TGFβ3 + ICA were added fibrin-cell constructions derived from adipose tissue stem cells. After 14 days, cell viability analyzed by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H- tetrazolium bromide assay and the expression of cartilage genes was evaluated with real-time polymerase chain reaction (RT-PCR). Results: The results showed ICA, TGFβ3, and TGFβ3 + ICA increased the rate of proliferation and viability of cells; but there were no significant differences between them (P > 0.05). Furthermore, quantitative RT-PCR analysis demonstrated that cooperation of ICA with TGFβ3 showed a better effect in expression of cartilaginous specific genes and increased Sox9, type II collagen, and aggrecan expression significantly. Furthermore, the results of the expression of type I and X collagens revealed that TGFβ3 increased the expression of them (P < 0.01); However, treatment with ICA + TGFβ3 down regulated the expression of these genes significantly. Conclusion: The results indicated ICA could be a potential factor for chondrogenesis and in cooperation with TGFβ3 could reduce its hypertrophic effects and it is a promising factor for cartilage tissue engineering.

1 March 2020 in International Electronic Journal of Medicine
Verified
Journal Article
Open access
PDF file
MRMohammad Zamani Rarani
Mohammad Zamani Rarani
FRFahimeh Zamani Rarani
Fahimeh Zamani Rarani
AVAli Valiani
Ali Valiani
ZDZeinolabedin Shrifian Dastjerdi
Zeinolabedin Shrifian Dastjerdi
EAElias Kargar Abargouei
Elias Kargar Abargouei
MDMehdi Nikbakht Dastjerdi
Mehdi Nikbakht Dastjerdi
Background: Adenosine receptor family, especially A1 type is-overexpressed in breast-derived tumor cells and the P53 gene is mutant in some of these cells while the casps gene is of wild type as well. The aim of this study was to evaluate the effect of the A1 receptor function on cell programmed death or proliferation, as well as the relationship between this receptor stimulation/inhibition and caspase 3 (casp3) expression in T47D cell line that has a mutant and non-functional P53 gene. Materials and Methods: The expression of casps3 was measured by real-time polymerase chain reaction and then flow cytometery and MTT assay were used to assess the apoptotic and proliferation cell rate after the treatment of T47D cells with specific agonist N6-cyclopentyladenosine (CPA) and antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) of this receptor 24, 48, and 72 hours after treatment. Result: Our results indicated that DPCPX significantly induces apoptosis in T47D cells and the rate of survival cell after the reduction of this treatment, especially 72 hours after treatment. Finally, the expression of casp3 was up-regulated by DPCPX treatment, especially in 72 hours while CPA treatment had opposite results (P>0.05). Conclusion: In general, DPCPX could up-regulate casp3 gene expression and subsequently increase the apoptosis rate in T47D cells with casp3 expression without the P53 gene interference. Therefore, adenosine A1 receptor antagonists may be introduced as anti-cancer agents.